Literature DB >> 16012152

Variability and growth in spending for outpatient specialty pharmaceuticals.

C Daniel Mullins1, Andrea R DeVries, Van Doren Hsu, Fanlun Meng, Francis B Palumbo.   

Abstract

Specialty pharmaceuticals are a unique group of drug agents used to treat complex clinical conditions. Many specialty pharmaceuticals are biological in nature and administered through injection or infusion. Tracking spending on these pharmaceuticals is complex, because these products may be processed as either medical or pharmacy claims. This benchmarking study of ten Blue Cross Blue Shield plans, representing almost eighteen million covered lives, documents large expenditures on select specialty pharmaceutical categories and much variation in spending across plans, age groups, and time. Our results underscore the need for insurers to scrutinize trends in specialty pharmaceutical spending and identify appropriate management strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012152     DOI: 10.1377/hlthaff.24.4.1117

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  9 in total

1.  Biosimilar growth hormone.

Authors:  Paul Saenger
Journal:  Indian J Pediatr       Date:  2011-11-23       Impact factor: 1.967

2.  Opportunity, resources, and affordability: multistakeholder perspectives.

Authors:  Janice L Clarke; Alexis Skoufalos; David B Nash; Eric Toppy
Journal:  Biotechnol Healthc       Date:  2009-04

3.  Growth hormone and health policy.

Authors:  Leona Cuttler; J B Silvers
Journal:  J Clin Endocrinol Metab       Date:  2010-04-28       Impact factor: 5.958

Review 4.  New challenges to medicare beneficiary access to mAbs.

Authors:  Joshua Cohen; Andrew Wilson
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

5.  Infused chemotherapy use in the elderly after patent expiration.

Authors:  Rena M Conti; Meredith B Rosenthal; Blase N Polite; Peter B Bach; Ya-Chen Tina Shih
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

6.  On specialty pharmaceuticals: reflections of a second-year medical student.

Authors:  Ross E Breitbart
Journal:  Biotechnol Healthc       Date:  2006-10

7.  The impact of rheumatoid arthritis and biologics on employers and payers.

Authors:  Paresh Chaudhari
Journal:  Biotechnol Healthc       Date:  2008-07

8.  Promotion of prescription drugs to consumers and providers, 2001-2010.

Authors:  Rachel Kornfield; Julie Donohue; Ernst R Berndt; G Caleb Alexander
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

9.  Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit.

Authors:  Juan F Sotos; Naomi J Tokar
Journal:  Int J Pediatr Endocrinol       Date:  2014-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.